Cargando…

The association between changes in muscle mass and quality of life in patients with metastatic colorectal cancer

BACKGROUND: Skeletal muscle mass (SMM) loss is common in metastatic colorectal cancer (mCRC) patients and associated with poor clinical outcomes, including increased treatment‐related toxicities and reduced survival. Muscle loss may contribute to reduced health‐related quality of life (HRQoL), inclu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Derksen, Jeroen W.G., Kurk, Sophie A., Peeters, Petra H.M., Dorresteijn, Bram, Jourdan, Marion, van der Velden, Ankie M.T., Nieboer, Peter, de Jong, Robert S., Honkoop, Aafke H., Punt, Cornelis J.A., Koopman, Miriam, May, Anne M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432557/ https://www.ncbi.nlm.nih.gov/pubmed/32107889 http://dx.doi.org/10.1002/jcsm.12562

Ejemplares similares

Impact of different palliative systemic treatments on skeletal muscle mass in metastatic colorectal cancer patients
por: Kurk, Sophie A., et al.
Publicado: (2018)

Trajectory of body mass and skeletal muscle indices and disease progression in metastatic colorectal cancer patients
por: Kurk, Sophie A, et al.
Publicado: (2019)

Factors Contributing to Cancer-Related Muscle Wasting During First-Line Systemic Treatment for Metastatic Colorectal Cancer
por: Derksen, Jeroen W G, et al.
Publicado: (2019)

Skeletal muscle mass loss and dose‐limiting toxicities in metastatic colorectal cancer patients
por: Kurk, Sophie, et al.
Publicado: (2019)

Loss of skeletal muscle index and survival in patients with metastatic colorectal cancer: Secondary analysis of the phase 3 CAIRO3 trial
por: Kurk, Sophie A., et al.
Publicado: (2019)

Management of cytotoxic chemotherapy-induced hand-foot syndrome
por: Kwakman, Johannes J.M., et al.
Publicado: (2020)

Feasibility of 7-T fluorine magnetic resonance spectroscopic imaging ((19)F MRSI) for TAS-102 metabolite detection in the liver of patients with metastatic colorectal cancer
por: Kurk, Sophie A., et al.
Publicado: (2018)

Informing metastatic colorectal cancer patients by quantifying multiple scenarios for survival time based on real‐life data
por: Hamers, Patricia A. H., et al.
Publicado: (2020)

Estimating adjuvant treatment effects in Stage II colon cancer: Comparing the synthesis of randomized clinical trial data to real‐world data
por: Jongeneel, Gabrielle, et al.
Publicado: (2019)

Translation of IDEA trial results into clinical practice: Analysis of the implementation of a new guideline for colon cancer
por: van Rooijen, Karlijn L., et al.
Publicado: (2022)

Live imaging of adult zebrafish cardiomyocyte proliferation ex vivo
por: Honkoop, Hessel, et al.
Publicado: (2021)

Colorectal Cancer Care and Patients’ Perceptions Before and During COVID-19: Implications for Subsequent SARS-CoV-2 Infection Waves
por: Derksen, Jeroen W G, et al.
Publicado: (2021)

Endothelium-Derived Extracellular Vesicles Associate with Poor Prognosis in Metastatic Colorectal Cancer
por: Nanou, Afroditi, et al.
Publicado: (2020)

Model-based evaluation of the cost effectiveness of 3 versus 6 months’ adjuvant chemotherapy in high-risk stage II colon cancer patients
por: Jongeneel, Gabrielle, et al.
Publicado: (2020)

Model-based effectiveness and cost-effectiveness of risk-based selection strategies for adjuvant chemotherapy in Dutch stage II colon cancer patients
por: Jongeneel, Gabrielle, et al.
Publicado: (2021)

DPA shows comparable chemotherapy sensitizing effects as EPA upon cellular incorporation in tumor cells
por: Dijk, Francina J., et al.
Publicado: (2019)

Reduced rate of copy number aberrations in mucinous colorectal carcinoma
por: Hugen, Niek, et al.
Publicado: (2015)

The CAIRO4 study: the role of surgery of the primary tumour with few or absent symptoms in patients with synchronous unresectable metastases of colorectal cancer – a randomized phase III study of the Dutch Colorectal Cancer Group (DCCG)
por: ’t Lam - Boer, Jorine, et al.
Publicado: (2014)

MicroRNA-143 is a putative predictive factor for the response to fluoropyrimidine-based chemotherapy in patients with metastatic colorectal cancer
por: Simmer, Femke, et al.
Publicado: (2015)

The Prospective Dutch Colorectal Cancer (PLCRC) cohort: real-world data facilitating research and clinical care
por: Derksen, Jeroen W. G., et al.
Publicado: (2021)

Survival of Patients with Deficient Mismatch Repair Versus Proficient Mismatch Repair Metastatic Colorectal Cancer Receiving Curative-Intent Local Treatment of Metastases in a Nationwide Cohort
por: Zwart, Koen, et al.
Publicado: (2023)

Open Wounds and Healed Scars: A Qualitative Study of Elderly Women's Experiences With Breast Cancer
por: van Ee, Birgit, et al.
Publicado: (2019)

Clinicopathological factors influencing outcome in metastatic colorectal cancer patients treated with fluoropyrimidine and bevacizumab maintenance treatment vs observation: an individual patient data meta-analysis of two phase 3 trials
por: Goey, Kaitlyn K H, et al.
Publicado: (2017)

Evaluation of the performance of algorithms mapping EORTC QLQ-C30 onto the EQ-5D index in a metastatic colorectal cancer cost-effectiveness model
por: Franken, Mira D., et al.
Publicado: (2020)

Longitudinal effects of adjuvant chemotherapy and related neuropathy on health utility in stage II and III colon cancer patients: A prospective cohort study
por: Jongeneel, Gabrielle, et al.
Publicado: (2021)

Genotypes of CYP2C8 and FGD4 and their association with peripheral neuropathy or early dose reduction in paclitaxel-treated breast cancer patients
por: Lam, Siu W, et al.
Publicado: (2016)

In vitro chemotherapy-associated muscle toxicity is attenuated with nutritional support, while treatment efficacy is retained
por: Wijler, Liza A., et al.
Publicado: (2022)

Systematic review of drug effects in humans and models with surfactant-processing disease
por: Klay, Dymph, et al.
Publicado: (2018)

Hypoxia-Targeting Fluorescent Nanobodies for Optical Molecular Imaging of Pre-Invasive Breast Cancer
por: van Brussel, Aram S. A., et al.
Publicado: (2015)

Design of the sex hormones and physical exercise (SHAPE) study
por: Monninkhof, Evelyn M, et al.
Publicado: (2007)

Beyond KRAS mutation status: influence of KRAS copy number status and microRNAs on clinical outcome to cetuximab in metastatic colorectal cancer patients
por: Mekenkamp, Leonie JM, et al.
Publicado: (2012)

Inventory of oncologists’ unmet needs for tools to support decision-making about palliative treatment for metastatic colorectal cancer
por: Engelhardt, Ellen G., et al.
Publicado: (2018)

Predicting early extrahepatic recurrence after local treatment of colorectal liver metastases
por: Wensink, G E, et al.
Publicado: (2023)

Time‐varying prognostic value of primary tumor sidedness in metastatic colorectal cancer: A population‐based study and meta‐analysis
por: van der Kruijssen, Dave E. W., et al.
Publicado: (2022)

Digit ratio (2D:4D) and altruism: evidence from a large, multi-ethnic sample
por: Galizzi, Matteo M., et al.
Publicado: (2015)

Specialized nutrition improves muscle function and physical activity without affecting chemotherapy efficacy in C26 tumour‐bearing mice
por: Wijler, Liza A., et al.
Publicado: (2021)

Patients’ Preferences for Information About the Benefits and Risks of Second-Line Palliative Chemotherapy and Their Oncologist’s Awareness of These Preferences
por: Oostendorp, Linda J. M., et al.
Publicado: (2015)

Prognostic Value of Resection of Primary Tumor in Patients with Stage IV Colorectal Cancer: Retrospective Analysis of Two Randomized Studies and a Review of the Literature
por: Venderbosch, Sabine, et al.
Publicado: (2011)

EMAST Is Associated with a Poor Prognosis in Microsatellite Instable Metastatic Colorectal Cancer
por: Venderbosch, Sabine, et al.
Publicado: (2015)

Asthma phenotypes in primary care
por: Honkoop, Persijn J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_q04kmfiq86rdif6h4msdo2f36g